Amosulalol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (RS)-5-[1-hydroxy-2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2- | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Identifiers | |
| CAS number | 85320-68-9 |
| ATC code | None |
| PubChem | CID 2169 |
| ChemSpider | 2084 |
| UNII | C69JI1BAU8 |
| KEGG | D07451 |
| ChEMBL | CHEMBL152231 |
| Chemical data | |
| Formula | C18H24N2O5S |
| Mol. mass | 380.45 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Amosulalol (INN) is a beta blocker.
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
|

